This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

SensCure Biotechnology Logo

Advancing Minimally Invasive Endoscopic Surgery

Focused on innovative cryotherapy technologies to serve human health through cutting-edge medical device development.

SensCure Biotechnology Lab

About SensCure Biotechnology

Ningbo SensCure Biotechnology Co., Ltd. is a high-tech enterprise specializing in medical devices, integrating independent research and development, production, and commercialization. We are committed to innovation in minimally invasive endoscopic surgery and cryotherapy technologies.

Our strong R&D team holds multiple patent licenses and has achieved ISO13485 Quality Management System certification. Our products have received regulatory approvals in China and the European Union, ensuring global compliance and safety.

ISO13485 Certified

Quality management in medical devices

Innovative R&D

Patent-protected technologies

Global Approvals

NMPA and EU regulatory clearance

Professional Team

High-caliber R&D specialists

Core Product Lines

We deliver innovative solutions in cryotherapy and minimally invasive endoscopic surgery for respiratory, urinary, and digestive diseases.

Cryotherapy Platform

Cryotherapy Products

A comprehensive cryotherapy platform featuring innovative devices for cryoablation in respiratory, urinary, and digestive disease treatments. Our system enables precise, minimally invasive tissue ablation with reduced recovery time.

  • Minimally invasive ablation
  • Treats airway tumors
  • Reduces re-narrowing frequency
  • NMPA & EU approved
Learn More
Endoscopic Surgery Tools

Non-Cryotherapy Products

Advanced solutions in minimally invasive endoscopic surgery, designed for precision, safety, and improved patient outcomes across multiple clinical applications.

  • High-precision instruments
  • Designed for ESD/EMR
  • Enhanced procedural control
  • Compatible with major endoscopes
Learn More

Featured Products

Malignant Airway Stenosis Cryoablation System

Malignant Airway Stenosis Cryoablation System

NMPA Approved: 20253010479 (Catheter), 20253010490 (Device)

  • • First in class respiratory cryoablation system
  • • Treats airway tumors via cryoablation
  • • Reduces re-narrowing frequency
  • • Minimally invasive, outpatient compatible
View Details →
Single-Use Cryoablation Catheter

Single-Use Cryoablation Catheter

Sterile, disposable, precision-engineered

  • • Designed for bronchoscopic use
  • • Flexible tip for airway navigation
  • • Optimized cryogen delivery
  • • CE and NMPA certified
View Details →
Endoscopic Submucosal Dissection Tools

Endoscopic Submucosal Dissection (ESD) Tools

High-precision surgical instruments

  • • For GI tract lesion removal
  • • Enhanced cutting and coagulation
  • • Ergonomic handle design
  • • Reusable and autoclavable
View Details →
Cryoablation Therapy Device

Cryoablation Therapy Device

Multi-application cryo platform

  • • Controls cryoablation catheters
  • • Real-time temperature monitoring
  • • Intuitive touchscreen interface
  • • Suitable for multiple specialties
View Details →
Endoscopic Grasping Forceps

Endoscopic Grasping Forceps

For biopsy and tissue manipulation

  • • Multiple jaw configurations
  • • Smooth articulation
  • • Single-use and reusable options
  • • High durability and precision
View Details →
R&D Laboratory Equipment

R&D Laboratory Systems

Innovation and testing platforms

  • • In-vitro cryo testing rigs
  • • Biomechanical simulation
  • • Data acquisition and analysis
  • • Supports clinical validation
View Details →
Urinary Tract Cryoablation Catheter

Urinary Tract Cryoablation Catheter

For urological applications

  • • Designed for ureteral access
  • • Treats transitional cell carcinoma
  • • Minimally invasive alternative
  • • Under clinical evaluation
View Details →
Digestive Endoscopic Cryo System

Digestive Endoscopic Cryo System

For gastrointestinal applications

  • • Treats early-stage GI tumors
  • • Compatible with standard endoscopes
  • • Low complication profile
  • • In development phase
View Details →

Innovative Research & Development

At SensCure, innovation is at the heart of everything we do. Our dedicated R&D team is focused on advancing minimally invasive technologies to improve patient outcomes and clinical efficiency.

We invest heavily in research, clinical collaboration, and technology integration to bring next-generation medical devices to market. Our pipeline includes novel cryoablation systems, smart endoscopic tools, and AI-assisted procedural platforms.

Recent Milestone

March 6, 2025: SensCure's Malignant Narrowing Cryoablation System received NMPA approval — marking the first respiratory cryoablation system approved in China for airway tumor treatment.

R&D Lab

Latest News & Updates

March 6, 2025 | Industry News

World's First Respiratory Interventional Balloon Cryoablation System Approved

Ningbo SensCure Biotechnology Co., Ltd. has received NMPA approval for its self-developed Malignant Narrowing Cryoablation System, including the "Single-Use Airway Cryoablation Catheter" (Registration No.: 20253010479) and "Cryo Therapy Device" (Registration No.: 20253010490). This is the first product in SensCure’s respiratory disease cryoablation series, designed to ablate airway tumor tissue and reduce the frequency of airway re-narrowing.

Read More →
July 1, 2024 | Business Collaboration

Kangfeng Bio Partners with Boston Scientific China

Kangfeng Bio has entered into a distribution agreement with Boston Scientific International Medical Trading (Shanghai) Co., Ltd. for respiratory intervention products in mainland China. Boston Scientific, a global leader in medical technology (NYSE: BSX), will distribute SensCure’s advanced cryoablation systems to expand access across China.

Read More →
April 17, 2024 | Event

SensCure at 2024 Shanghai Digestive Endoscopy Conference

SensCure showcased its latest endoscopic innovations at the 16th China-Japan ESD Forum in Shanghai. The event attracted 3,681 attendees and over 180,000 online viewers, highlighting the growing interest in advanced endoscopic techniques and minimally invasive therapies.

Read More →

Contact SensCure Biotechnology

For inquiries, partnerships, or product information, please visit our official website.

Contact Information

Phone: +86 574-6372-9798

Email: [email protected]

Address: Building 3, Area B, No. 777, Binhai 4th Road, Hangzhou Bay New District, Ningbo City, Zhejiang Province, China

Visit Official Website

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact [email protected]

如果您是其他域名合作 也请联系[email protected]